Cannabinoid hyperemesis syndrome.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BMJ Pub. Group
    • Subject Terms:
      Vomiting*/chemically induced ; Abdominal Pain*/chemically induced ; Cannabinoids*/adverse effects; Humans ; Adult ; Male ; Syndrome ; Nausea/chemically induced ; Marijuana Abuse/complications ; Antiemetics/adverse effects ; Cannabinoid Hyperemesis Syndrome
    • Abstract:
      SummaryCannabis use is legalised in many countries. We present a patient in their 40s who complained of recurrent abdominal pain and associated nausea and vomiting. The patient was previously seen in various hospitals, treated symptomatically, and discharged with a diagnosis of non-specific abdominal pain. The patient had a chronic history of smoking cannabis and nicotine and drinking alcohol. Abdominal examination revealed no masses, and abdominal X-ray was normal. Blood tests and gastroduodenoscopy revealed no obvious aetiology. Intravenous fluids, together with antiemetics and proton pump inhibitors, were administered. The patient also received counselling and was advised to stop cannabis use. At discharge, the patient was well and asked to come back for review in 2 weeks, and, thereafter monthly for a period of 6 months after stopping cannabis use. The patient reported no recurrent symptoms despite continued cigarette and alcohol use. A suspected cannabinoid hyperemesis syndrome (CHS) became a consideration. Awareness of cannabis-related disorders such as CHS may assist in avoiding costly hospital workups.
      Competing Interests: Competing interests: None declared.
      (© BMJ Publishing Group Limited 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
    • References:
      West J Emerg Med. 2018 Mar;19(2):380-386. (PMID: 29560069)
      Med Princ Pract. 2022;31(1):29-38. (PMID: 34724666)
      Gut. 2004 Nov;53(11):1566-70. (PMID: 15479672)
      J Comp Neurol. 2003 Oct 6;465(1):121-35. (PMID: 12926020)
      ACG Case Rep J. 2018 Jan 3;5:e3. (PMID: 29379817)
      BMJ Case Rep. 2018 Oct 14;2018:. (PMID: 30323105)
      Clin Toxicol (Phila). 2018 Jan;56(1):15-24. (PMID: 28730896)
      Gastroenterology. 2016 May;150(6):1257-61. (PMID: 27147121)
      Gastroenterology. 2016 May;150(6):1380-92. (PMID: 27147122)
    • Contributed Indexing:
      Keywords: Endoscopy; Gastroenterology; Gastrointestinal system; Pain; Pancreatitis
    • Accession Number:
      0 (Cannabinoids)
      0 (Antiemetics)
    • Publication Date:
      Date Created: 20240430 Date Completed: 20240430 Latest Revision: 20240512
    • Publication Date:
      20240512
    • Accession Number:
      PMC11085687
    • Accession Number:
      10.1136/bcr-2023-256921
    • Accession Number:
      38688569